Tg(Igh*-Mir125b-1)005-2Toki
Transgene Detail
|
|
| Symbol: |
Tg(Igh*-Mir125b-1)005-2Toki |
| Name: |
transgene insertion 005-2, Toshio Kitamura |
| MGI ID: |
MGI:7514971 |
| Synonyms: |
Tg(IGHEmu/VH-preMir125b-1)005-2Wakh |
| Transgene: |
Tg(Igh*-Mir125b-1)005-2Toki Location: unknown Genetic Position: Chr5, Syntenic
|
| Alliance: |
Tg(Igh*-Mir125b-1)005-2Toki page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Igh*-Mir125b-1)005-2Toki expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| mouse |
Mir125b-1 (MGI:2676810) |
|
|
| |
|
Mutation details: The human Emu enhancer with the Igh promoter drives late pro-B cell-specific expression of the mouse pre-microRNA inserted into the rabbit beta-globin gene.
(J:178816)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:178816 Enomoto Y, et al., Emu/miR-125b transgenic mice develop lethal B-cell malignancies. Leukemia. 2011 Dec;25(12):1849-56 |
| All: |
1 reference(s) |
|